![PPT - CHARM Program: 3 Component trials comparing candesartan with placebo PowerPoint Presentation - ID:778750 PPT - CHARM Program: 3 Component trials comparing candesartan with placebo PowerPoint Presentation - ID:778750](https://cdn0.slideserve.com/232610/candesartan-in-heart-failure-dt.jpg)
PPT - CHARM Program: 3 Component trials comparing candesartan with placebo PowerPoint Presentation - ID:778750
![Cumulative number of hospital admissions: CHARM-Alternative (top left),... | Download Scientific Diagram Cumulative number of hospital admissions: CHARM-Alternative (top left),... | Download Scientific Diagram](https://www.researchgate.net/publication/7027665/figure/fig1/AS:601667225526322@1520460053674/Cumulative-number-of-hospital-admissions-CHARM-Alternative-top-left-CHARM-Added-top.png)
Cumulative number of hospital admissions: CHARM-Alternative (top left),... | Download Scientific Diagram
![Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial - ScienceDirect Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673603142857-gr2.gif)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial - ScienceDirect
![Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial - ScienceDirect Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673603142857-gr1.gif)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial - ScienceDirect
Candesartan in Heart Failure Candesartan in Heart Failure | PDF | Heart Failure | Medical Treatments
![Results of the CHARM trial program. 52–55 Notes: *p for heterogeneity... | Download Scientific Diagram Results of the CHARM trial program. 52–55 Notes: *p for heterogeneity... | Download Scientific Diagram](https://www.researchgate.net/publication/40895788/figure/fig5/AS:339640008626189@1457987896773/Results-of-the-CHARM-trial-program-52-55-Notes-p-for-heterogeneity-037-p-for.png)
Results of the CHARM trial program. 52–55 Notes: *p for heterogeneity... | Download Scientific Diagram
![CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin. CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.](https://slideplayer.com/6366564/22/images/slide_1.jpg)
CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.
![Candesartan in Heart Failure Presented at European Society of Cardiology 2003 CHARM Trial. - ppt download Candesartan in Heart Failure Presented at European Society of Cardiology 2003 CHARM Trial. - ppt download](https://images.slideplayer.com/32/9852680/slides/slide_7.jpg)
Candesartan in Heart Failure Presented at European Society of Cardiology 2003 CHARM Trial. - ppt download
![Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial - ScienceDirect Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673603142833-gr2.gif)